Lipocalin 2 and Lung Metastasis in Breast Cancer
Author Information
Author(s): Shi Han, Gu Yuchao, Yang Jing, Xu Liang, Mi Wenyi, Yu Wengong
Primary Institution: Department of Molecular Biology, School of Medicine and Pharmacy, Ocean University of China
Hypothesis
This study aimed to investigate the roles of lipocalin 2 in breast tumor metastasis.
Conclusion
Lipocalin 2 promotes lung metastasis of 4T1 cells through the inhibition of the PI3K/Akt pathway.
Supporting Evidence
- Lipocalin 2 overexpression significantly enhanced the migration and invasion abilities of 4T1 cells in vitro.
- In vivo, lipocalin 2 increased the number of visible metastatic nodules on the lung surface of tumor-bearing mice.
- The inhibition of the PI3K/Akt pathway was identified as a mechanism for the promotion of breast cancer migration/invasion.
Takeaway
Lipocalin 2 helps breast cancer cells move to the lungs, which can make the cancer spread more.
Methodology
Lipocalin 2 was overexpressed in 4T1 murine mammary cancer cells, and various assays were conducted to assess cell behavior in vitro and in vivo.
Limitations
The study primarily focused on a single cell line and may not represent all breast cancer types.
Participant Demographics
Female BALB/c mice, aged 8 to 10 weeks.
Statistical Information
P-Value
p<0.05
Statistical Significance
p<0.05
Digital Object Identifier (DOI)
Want to read the original?
Access the complete publication on the publisher's website